What works for whom in pharmacist-led smoking cessation support: Realist review

BMC Medicine

Volumn 14, Issue 1, 2016, Pages

  Greenhalgh, Trisha ^a   Macfarlane, Fraser ^b   Steed, Liz ^b   Walton, Robert ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR CHANGE; COST EFFECTIVENESS ANALYSIS; EMPIRICISM; HUMAN; IDENTITY; INTERVENTION STUDY; LIFESTYLE; MEDLINE; MOTIVATION; NARRATIVE; PHARMACIST; PHARMACY; PSYCHOLOGICAL THEORY; QUALITATIVE RESEARCH; QUANTITATIVE STUDY; SMOKING CESSATION; STAFF; SYSTEMATIC REVIEW; THEORETICAL MODEL; TRUST; PHARMACY (SHOP); PROCEDURES;

HUMANS; PHARMACIES; PHARMACISTS; QUALITATIVE RESEARCH; SMOKING CESSATION;

EID: 85006039306     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-016-0749-5     Document Type: Article

References (84)

1. The National Health Service (Pharmaceutical Services) Regulations 2005. No 641. Leeds: Stationery Office; 2005.
2. Noyce PR. Providing patient care through community pharmacies in the UK: policy, practice, and research. Ann Pharmacother. 2007;41(5):861-8.
3. Saramunee K, Krska J, Mackridge A, Richards J, Suttajit S, Phillips-Howard P. How to enhance public health service utilization in community pharmacy?: General public and health providers' perspectives. Res Soc Adm Pharm. 2014;10(2):272-84.
4. Brown D, Portlock J, Rutter P. Review of services provided by pharmacies that promote healthy living. Int J Clin Pharm. 2012;34:399-409.
5. Walton R. Optimising pharmacist-based treatment for smoking cessation (study outline). Leeds: National Institute for Health Research; 2012. http://www.hra.nhs.uk/news/research-summaries/stop-smoking-cessation-treatment-optimisation-inpharmacies/. Accessed 26 Nov 2016.
6. Steed L, Kassavou A, Madurasinghe VW, Edwards EA, Todd A, Summerbell CD, Nkansah N, Bero L, Durieux P, Taylor SJ. Community pharmacy interventions for health promotion: effects on professional practice and health outcomes. Cochrane Database Syst Rev. 2014;7:CD011207. 2014.
7. Pawson R, Greenhalgh T, Harvey G, Walshe K. Realist review--a new method of systematic review designed for complex policy interventions. J Health Serv Res Policy. 2005;10 Suppl 1:21-34.
8. Astbury B, Leeuw FL. Unpacking black boxes: mechanisms and theory building in evaluation. Am J Eval. 2010;31(3):363-81.
9. Wong G, Greenhalgh T, Westhorp G, Buckingham J, Pawson R. RAMESES publication standards: realist syntheses. BMC Med. 2013;11:21.
10. Steed L, Kassavou A, Madurasinghe VW, Edwards EA, Todd A, Summerbell CD, Nkansah N, Bero L, Durieux P, Taylor SJ. Protocol: Community pharmacy interventions for health promotion: effects on professional practice and health outcomes. The Cochrane Library. 2014. http://www.cochrane.org/CD011207/EPOC_community-pharmacy-interventions-for-health-promotion-effects-on-professional-practice-and-health-outcomes. Accessed 26 Nov 2016.
11. Greenhalgh T, Peacock R. Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources. BMJ. 2005;331(7524):1064-5.
12. Øvretveit J. Reviewing Medical Management Research for Decision- Makers: Methodological Issues in Carrying Out Systematic Reviews of Medical Management Research. Stockholm: Karolinska Institute (Medical Management Centre internal discussion document); 2003.
13. Anderson C, Blenkinsopp A, Armstrong M. Pharmacists' perceptions regarding their contribution to improving the public's health: a systematic review of the United Kingdom and international literature 1990-2001. Int J Pharm Pract. 2003;11:111-20.
14. Smith A, Darracott R. Modrnising Pharmacy Careers Programme. Review of pharmacist undergraduate education and pre-registration training and proposals for reform. London: Medical Education England 2011. https://hee.nhs.uk/sites/default/files/documents/Pharmacist-pre-registration-training-proposals-for-reform.pdf. Accessed 23 Sept 2016.
15. Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med. 2003;25(2):144-53.
16. Mdege ND, Chindove S. Effectiveness of tobacco use cessation interventions delivered by pharmacy personnel: a systematic review. Res Soc Adm Pharm. 2014;10(1):21-44.
17. Nkansah N, Mostovetsky O, Yu C, Chheng T, Beney J, Bond CM, Bero L. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev. 2010;7:CD000336. doi: 10.1002/14651858CD000336pub2. 2010:p1-88.
18. Sinclair HK, Bond CM, Stead LF. Community pharmacy personnel interventions for smoking cessation. Cochrane Database Syst Rev. 2008;1:CD003698. doi: 10.1002/14651858CD003698pub2. 2008:1-15.
19. Brown TJ, Todd A, O'Malley C, Moore HJ, Husband AK, Bambra C, Kasim A, Sniehotta FF, Steed L, Smith S. Community pharmacy-delivered interventions for public health priorities: a systematic review of interventions for alcohol reduction, smoking cessation and weight management, including meta-analysis for smoking cessation. BMJ Open. 2016;6(2), e009828.
20. Okumura LM, Rotta I, Correr CJ. Assessment of pharmacist-led patient counseling in randomized controlled trials: a systematic review. Int J Clin Pharm. 2014;36(5):882-91.
21. Bennett MI, Bagnall A-M, Raine G, Closs SJ, Blenkinsopp A, Dickman A, Ellershaw J. Educational interventions by pharmacists to patients with chronic pain: systematic review and meta-analysis. Clin J Pain. 2011;27(7):623-30.
22. Tombor I, Shabab L, Herbec A, Neale J, Michie S, West R. Smoker identity and its potential role in young adults' smoking behaviour: a meta-ethnography. Health Psychol. 2015;34(10):992-1003.
23. Blom L, Krass I. Introduction: the role of pharmacy in patient education and counseling. Patient Educ Couns. 2011;83:285-7.
24. Holdford D, Kennedy DT, Bernadella P, Small RE. Implementing disease management in community pharmacy practice. Clin Ther. 1998;20(2):328-39.
25. International Pharmaceutical Federation. Advanced practice and specialisation in pharmacy: Global report. The Hague, Netherlands: IPF; 2015. http://www.fip.org/educationreports. Accessed 28 March 2016.
26. Mossialos E, Naci H, Courtin E. Expanding the role of community pharmacists: Policymaking in the absence of policy-relevant evidence. Health Policy. 2013;111:135-48.
27. Roche C, Kelliher F. Giving "best advice": Proposing a framework of community pharmacist professional judgement formation. Pharmacy. 2014;2(1):74-85.
28. Sinclair H, Bond C, Lennox A, Silcock J, Winfield A. Knowledge of and attitudes to smoking cessation: the effect of stage of change training for community pharmacy staff. Health Bull. 1998;56(1):526-39.
29. Taylor J, Semchuk W, Deschamps M, Sulz L, Tsuyuki RT, Duffy P, Wilson T. Pharmacist intervention in risk reduction study in high-risk cardiac patients: The effect of 2 methods of pharmacist training. Can Pharm J. 2007;140(2):116-23.
30. Armitage CJ, Arden MA. How useful are the stages of change for targeting interventions? Randomized test of a brief intervention to reduce smoking. Health Psychol. 2008;27(6):789-98.
31. Bauld L, Chesterman J, Ferguson J, Judge K. A comparison of the effectiveness of group-based and pharmacy-led smoking cessation treatment in Glasgow. Addiction. 2009;104:308-16.
32. Bock BC, Hudmon KS, Christian J, Graham AL, Bock FR. A tailored intervention to support pharmacy-based counseling for smoking cessation. Nicotine Tob Res. 2010;12(3):217-25.
33. Burford O. Delivering a personalised smoking cessation intervention by community pharmacists in Western Australia: a randomised controlled trial. PhD Thesis. Perth: Curtin University, School of Pharmacy; 2012.
34. Costello MJ, Sproule B, Victor JC, Leatherdale ST, Zawetailo L, Selby P. Effectiveness of pharmacist counseling combined with nicotine replacement therapy: a pragmatic randomized trial with 6,987 smokers. Cancer Causes Control. 2011;22:167-80.
35. Crealey GE, McElnay JC, Maguire TA, O'Neill C. Costs and effects associated with a community pharmacy-based smoking-cessation programme. Pharmacoeconomics. 1998;14(3):323-33.
36. Dent LA, Harris KJ, Noonan CW. Randomized trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation. Ann Pharmacother. 2009;43:194-201.
37. Hoving C, Mudde AN, Dijk F, de Vries H. Effectiveness of a smoking cessation intervention in Dutch pharmacies and general practices. Health Educ. 2010;110(1):17-29.
38. Maguire TA, McElnay JC, Drummond A. A randomized controlled trial of a smoking cessation intervention based in community pharmacies. Addiction. 2001;96:325-31.
39. McEwen A, West R, McRobbie H. Effectiveness of specialist group treatment for smoking cessation vs. one-to-one treatment in primary care. Addict Behav. 2006;31:1650-60.
40. Sinclair HK, Silcock J, Bond CM, Lennox S, Winfield AJ. The cost-effectiveness of intensive pharmaceutical intervention in assisting people to stop smoking. Int J Pharm Pract. 1999;7:107-12.
41. Vial RJ, Jones TE, Ruffin RE, Gilbert AL. Smoking cessation programme using nicotine patches linking hospital to the community. J Pharm Pract Res. 2002;32(1):57-62.
42. Weinberger M, Murray MD, Marrero DG, Brewer N, Lykens M, Harris LE, Seshadri R, Caffrey H, Roesner JF, Smith F. Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial. JAMA. 2002;288(13):1594-602.
43. McLean W, Gillis J, Waller R. The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Can Respir J. 2002;10(4):195-202.
44. Phimarn W, Pianchana P, Limpikanchakovit P, Suranart K, Supapanichsakul S, Narkgoen A, Saramunee K. Thai community pharmacist involvement in weight management in primary care to improve patient's outcomes. Int J Clin Pharm. 2013;35(6):1208-17.
45. Tobari H, Arimoto T, Shimojo N, Yuhara K, Noda H, Yamagishi K, Iso H. Physician-pharmacist cooperation programme for blood pressure control in patients with hypertension: a randomized-controlled trial. Am J Hypertens. 2010;23(10):1144-52.
46. Corelli RL, Zillich AJ, de Moor C, Giuliano MR, Arnold J, Fenlon CM, Douglas CL, Magnusson B, Zbikowski SM, Prokhorov AV. Recruitment of community pharmacies in a randomized trial to generate patient referrals to the tobacco quitline. Res Soc Adm Pharm. 2013;9(4):396-404.
47. Anderson C. A controlled study of the effect of a health promotion training scheme on pharmacists' advice about smoking cessation. J Soc Adm Pharm. 1995;12(3):115-24.
48. Liekens S, Vandael E, Roter D, Larson S, Smits T, Laekeman G, Foulon V. Impact of training on pharmacists' counseling of patients starting antidepressant therapy. Patient Educ Couns. 2014;94(1):110-5.
49. Martin BA, Chewning BA. Evaluating pharmacists' ability to counsel on tobacco cessation using two standardized patient scenarios. Patient Educ Couns. 2011;83:319-24.
50. Mayer JA, Eckhardt L, Stepanski BM, Sallis JF, Elder JP, Slymen DJ, Creech L, Graf G, Palmer RC, Rosenberg C. Promoting skin cancer prevention counseling by pharmacists. Am J Public Health. 1998;88(7):1096-9.
51. Mayer JA, Slymen DJ, Eckhardt L, Rosenberg C, Stepanski BM, Creech L, Palmer RC, Elder JP, Graf G, Anderson ST. Skin cancer prevention counseling by pharmacists: specific outcomes of an intervention trial. Cancer Detect Prev. 1997;22(4):367-75.
52. Patwardhan PD, Chewning BA. Effectiveness of intervention to implement tobacco cessation counseling in community chain pharmacies. J Am Pharm Assoc. 2012;52(4):507-14.
53. Prokhorov AV, Suchanek Hudmon K, Marani S, Foxhall L, Ford KH, Stanic Luca N, Wetter DW, Cantor SB, Vitale F, Gritz ER. Engaging physicians and pharmacists in providing smoking cessation counseling. Arch Intern Med. 2010;170(18):1640-6.
54. Sinclair H, Bond C, Lennox AS, Silcock J, Winfield A. An evaluation of a training workshop for pharmacists based on the Stages of Change model of smoking cessation. Health Educ J. 1997;56:296-312.
55. Sinclair HK, Bond CM, Lennox S, Silcock J, Winfield AJ, Donnan PT. Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: a randomised controlled trial in Scotland. Tob Control. 1998;7:253-61.
56. Sinclair HK, Bond CM, Lennox AS. The long-term learning effect of training in stage of change for smoking cessation: a three-year follow up of community pharmacy staff's knowledge and attitudes. Int J Pharm Pract. 1999;7(1):1-11.
57. McMillan SS, Kelly F, Sav A, King MA, Whitty JA, Wheeler AJ. Australian community pharmacy services: a survey of what people with chronic conditions and their carers use versus what they consider important. BMJ Open. 2014;4(12), e006587.
58. Whitty JA, Kendall E, Sav A, Kelly F, McMillan SS, King MA, Wheeler AJ. Preferences for the delivery of community pharmacy services to help manage chronic conditions. Res Soc Adm Pharm. 2015;11:197-215.
59. Aquilino ML, Farris KB, Zillich AJ, Lowe JB. Smoking-cessation services in Iowa community pharmacies. Pharmacotherapy. 2003;23(5):666-73.
60. El Hajj MS, Al Nakeeb RR. Smoking cessation counseling in Qatar: community pharmacists' attitudes, role perceptions and practices. Int J Clin Pharm. 2012;34(4):667-76.
61. Hudmon KS, Prokhorov AV, Corelli RL. Tobacco cessation counseling: pharmacists' opinions and practices. Patient Educ Couns. 2006;61(1):152-60.
62. Rene-Henri N, Khamla Y, Nadaira N, Ouellet C, Blais L, Lalonde L, Collin J, Beauchesne M-F. Community pharmacists' interventions in asthma care: a descriptive study. Ann Pharmacother. 2009;43:104-11.
63. An LC, Foldes SS, Alesci NL, Bluhm JH, Bland PC, Davern ME, Schillo BA, Ahluwalia JS, Manley MW. The impact of smoking-cessation intervention by multiple health professionals. Am J Prev Med. 2008;34(1):54-60.
64. Kradjan WA, Schulz R, Christensen DB, Stergachis A, Sullivan S, Fullerton D, Sturm L, Schneider G. Patients' perceived benefit from and satisfaction with asthma-related pharmacy services. J Am Pharm Assoc. 1998;39(5):658-66.
65. Rapport F, Doel MA, Hutchings HA, Wright S, Wainwright P, John DN, Jerzembek GS. Eleven themes of patient-centred professionalism in community pharmacy: innovative approaches to consulting. Int J Pharm Pract. 2010;18(5):260-8.
66. Elvey R, Hassell K, Lewis P, Schafheutle E, Willis S, Harrison S. Patient-centred professionalism in pharmacy: values and behaviours. J Health Organ Manag. 2015;29(3):413-30.
67. Feletto E, Wilson LK, Roberts AS, Benrimoj SI. Flexibility in community pharmacy: a qualitative study of business models and cognitive services. Pharm World Sci. 2010;32(2):130-8.
68. Maher JH, Nut Diet M, Lowe JB, Hughes R, Anderson C. Understanding community pharmacy intervention practice: lessons from intervention researchers. Res Soc Adm Pharm. 2014;10:633-46.
69. Gidman W, Ward P, McGregor L. Understanding public trust in services provided by community pharmacists relative to those provided by general practitioners: a qualitative study. BMJ Open. 2012;2(3), e000939.
70. García PJ, Carcamo CP, Garnett GP, Campos PE, Holmes KK. Improved STD syndrome management by a network of clinicians and pharmacy workers in Peru: the PREVEN Network. PLoS One. 2012;7(10), e47750.
71. Vitale F. Professional intervention for smoking cessation: the contribution of the pharmacist. Eur J Public Health. 2000;10(3 supplement):21-4.
72. Martins SF, van Mil JF, da Costa FA. The organizational framework of community pharmacies in Europe. Int J Clin Pharm. 2015;37(5):896-905.
73. Weinberger M, Murray MD, Marrero DG, Brewer N, Lykens M, Harris LE, Tierney WM. Pharmaceutical care program for patients with reactive airways disease. Am J Health Syst Pharm. 2001;58(9):791-6.
74. Patwardhan PD, Amin ME, Chewning B. Intervention research to enhance community pharmacists' cognitive services: a systematic review. Res Soc Adm Pharm. 2014;10:475-93.
75. Carson KV, Verbiest ME, Crone MR, Brinn MP, Esterman AJ, Assendelft WJ, Smith BJ. Training health professionals in smoking cessation. Cochrane Database Syst Rev. 2012;5, CD000214.
76. Bernsten C, Andersson K, Gariepy Y, Simoens S. A comparative analysis of remuneration models for pharmaceutical professional services. Health Policy. 2010;95(1):1-9.
77. Anderson C, Bates I, Beck D, Brock TP, Futter B, Mercer H, Rouse M, Whitmarsh S, Wuliji T, Yonemura A. The WHO UNESCO FIP pharmacy education taskforce. Hum Resour Health. 2009;7:45.
78. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179-211.
79. Bandura A. Social learning theory. Englewood Cliffs: Prentice-Hall; 1976.
80. Rogers EM. Diffusion of innovations (5th edition). New York, NY: Simon and Schuster; 2010.
81. Grol R, Wensing M. What drives change? Barriers to and incentives for achieving evidence-based practice. Med J Aust. 2004;180(6 Suppl):S57.
82. Sohanpal R, Rivas C, Steed L, MacNeill V, Kuan V, Edwards E, Griffiths C, Eldridge S, Taylor S, Walton R. Understanding recruitment and retention in the NHS community pharmacy stop smoking service: perceptions of smoking cessation advisers. BMJ Open. 2016;6(7), e010921.
83. Michie S, West R, Campbell R, Brown J, Gainforth H. ABC of Behaviour Change Theories: An Essential Resource for Researchers, Policy Makers and Practitioners. London: Silverback Publishing; 2014.
84. Resar R, Griffin FA, Haraden C, Nolan TW. Using Care Bundles to Improve Health Care Quality. IHI Innovation Series white paper. Cambridge: Massachusetts Institute for Healthcare Improvement; 2012. http://www.ihi.org/resources/pages/ihiwhitepapers/usingcarebundles.aspx. Accessed 19 Sept 2016.